Skip to main content
. 2021 Jul 7;8(2):e001685. doi: 10.1136/openhrt-2021-001685

Table 3.

Characteristics of patient with low flow/low gradient AS

Low-flow, low-gradient AS Normal-flow, high-gradient Significance
(p value)
n=10 n=90
AVA baseline (cm2) 0.73±0.14 0.76±0.15 0.571
AV mean gradient baseline (mm Hg) 26.2±3.8 50.3±11.7 <0.001
PASP baseline (mm Hg) 39.3±12.7
%
39.5±11.8
%
0.966
LVEF baseline (%) 36.9±6.7 55.4±7.3 <0.001
LVEDD baseline (mm) 55.3±9.1 49.8±5.4 0.006
LVESD baseline (mm) 43.8±10.7 32.6±6 <0.001
IVSd (mm) 11.6±1.3 13.1±1.6 0.006
TAPSE baseline (mm) 18.8±2.4 22±2.6 0.005
E/A 0.8±0.6 0.7±0.3 0.501
E/E‘ average 15±6 13.5±2.8 0.234
EuroSCORE II baseline (%) 12.0±13.4 5.1±3.4 <0.001
LAS, pre-TAVR 10.6±4.8 15.6±5.9 0.011
ΔLAS −1.08±4.46% 0.36±4.95% 0.407
LAVi, pre-TAVR (mL/m2) 49.7±22.5 48.1±13.1 0.791
ΔLAVi −8.1±15.7 −11.6±17.4 0.672

AS, aortic stenosis; AV, aortic valve; AVA, aortic valve area; E/A, early-to-late diastolic flow ratio; E/E’, E-to-mean E’ ratio; IVSd, interventricular septal diameter diastolic; LAS, left atrial strain; LAVi, left atrial volume index; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic diameter; PASP, pulmonary artery systolic pressure; TAPSE, tricuspid annular plane excursion; TAVR, transcatheter aortic valve replacement.